Arthur Michael Mandell's most recent trade in MaxCyte Inc was a trade of 40,701 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MaxCyte Inc | Arthur Michael Mandell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 40,701 | 40,701 | - | - | Stock Option (right to buy) | |
| MaxCyte Inc | Arthur Michael Mandell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 21,367 | 395,851 | - | 0 | Common Stock |